Eli Lilly Co Drug Patent Portfolio

Eli Lilly Co's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Eli Lilly Co News

The Leading GLP-1 Manufacturer Expands Its Advantage as the Versatile Healthcare Corporation Reports ...

10 Jan, 2026

Lilly expands its portfolio beyond major obesity medications by acquiring Ventyx for $1.2 billion.

09 Jan, 2026

Anticipations for AbbVie's Immunology Division in the Fourth Quarter - TradingView

09 Jan, 2026

Anticipations for AbbVie's Immunology Division in the Fourth Quarter

09 Jan, 2026

See More